Skip to content

Press Releases

年 : 2020

日付 タイトル
2020/11/18 Illumina to Webcast Upcoming Investor Conference Presentation
2020/11/12 P3試薬キットのパワーでNextSeq 2000システムの潜在能力をフルに活用
2020/10/29 Illumina Reports Financial Results for Third Quarter of Fiscal Year 2020
2020/09/28 Illumina to Announce Third Quarter 2020 Financial Results on Thursday, October 29, 2020
2020/09/23 Illumina to Webcast Upcoming Investor Conference Presentation
2020/09/21 イルミナ、がん発見の新時代構築に向けて、GRAILを買収
2020/09/14 Genomic Leaders Collaborate to Create Australia’s First National COVID-19 Tracking System
2020/08/25 Illumina Welcomes Kathryne Reeves as Chief Marketing Officer
2020/08/07 Illumina to Webcast Upcoming Investor Conference Presentation
2020/08/06 NovaSeq™ 6000 v1.5 Reagent Kitの発売を発表、$600ゲノムでより深い知見の取得が可能に
2020/08/06 Illumina Reports Financial Results for Second Quarter of Fiscal Year 2020
2020/07/16 Illumina to Announce Second Quarter 2020 Financial Results on Thursday, August 6, 2020
2020/07/08 Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases
2020/06/23 Illumina Accelerator Welcomes First Global Cohort of Genomics Startups
2020/06/17 Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale
2020/06/16 イルミナ、米国連邦裁判所がBGI各社に対して予備的差止命令を発令したことを発表
2020/06/09 Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test
2020/05/18 Illumina, Inc. and the Illumina Corporate Foundation Commit $10 Million to COVID-19 Response and Research
2020/05/04 Illumina Welcomes Alex Aravanis as Chief Technology Officer and Appoints Mostafa Ronaghi to Lead Entrepreneurial Development
2020/04/30 Illumina Reports Financial Results for First Quarter of Fiscal Year 2020
2020/04/28 Illumina’s Donation to the Africa Centre for Disease Control and Prevention Expands their Capability for Sequencing-Based COVID-19 Surveillance
2020/04/16 Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19
2020/04/14 Illumina Reports Preliminary Revenue for First Quarter of Fiscal Year 2020
2020/02/27 Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.
2020/02/12 Illumina to Webcast Upcoming Investor Conference Presentations
2020/02/06 Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors
2020/01/29 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019
2020/01/13 新しいシーケンスシステム、Rocheとのパートナーシップ、およびゲノミクスの導入を促進するソフトウェアスイートを発表
2020/01/13 イルミナとロシュ、がんゲノム検査をより多くの患者に届けるために提携
2020/01/13 Illumina to Announce Fourth Quarter and Fiscal Year 2019 Financial Results on Wednesday, January 29, 2020
2020/01/10 Illumina Files Patent Infringement Suits Against BGI in Sweden and the United Kingdom
2020/01/02 Illumina and Pacific Biosciences Announce Termination of Merger Agreement